| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| intedanib | fibroblast growth factor receptor 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hamman-Rich syndrome[MeSHID:D011658] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Colorectal Cancer[MeSHID:D015179] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant neoplasm of ovary[MeSHID:D010051] Mesothelioma[MeSHID:D008654] |
0.34 | approved | unknown |
| intedanib | fms-like tyrosine kinase 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hamman-Rich syndrome[MeSHID:D011658] Idiopathic Pulmonary Fibrosis[MeSHID:D054990] Colorectal Cancer[MeSHID:D015179] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant neoplasm of ovary[MeSHID:D010051] Mesothelioma[MeSHID:D008654] |
0.09 | approved | unknown |
| click here to return to the previous page | ||||||||